Karolinska Institutet

A new blood test called Stockholm3 detects 90% of aggressive prostate cancer cases, outperforming the traditional PSA test which detects 74%. A study involving 12,000 men found Stockholm3 missed significantly fewer serious cases without increasing unnecessary follow-ups.

A study links anemia to increased cancer risk and mortality, finding new-onset anemia correlates with higher cancer diagnosis rates and all-cause death within 18 months. The research, conducted in Sweden and published in BMJ Journals, highlights specific anemia types like microcytic and macrocytic as risk factors for different health outcomes.